Altre lingue Swedish Orphan Biovitrum AB

Azioni

SOBI

SE0000872095

Tempo reale stimato Cboe Europe Altri mercati azionari 14:32:10 18/04/2024			Variaz. 5gg	Var. 1 gen.
257,6 ^SEK	+0,70%		+1,02%	-3,15%

13/02	Sobi si espanderà in Corea del Sud attraverso una joint venture per le malattie rare con Handok	MT
12/02	Orexo, Swedish Orphan Biovitrum esploreranno ulteriormente la combinazione AmorphOX	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Invitation: Sobi's Q1 2024 report	15/04
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)	04/04
Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023	02/04
Sobi publishes Annual and sustainability report for 2023	02/04
Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP	25/03
Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024.	14/03
AVIS D'ANALYSTES DU JOUR : Air Liquide, Carrefour, STMicro, Sartorius Stedim Biotech, Schneider, Soitec...	22/02
OPINIONES DE LOS ANALISTAS DEL DÍA : Inditex, Acciona Energia, Merlin Properties, Tod's, Euronext, ...	22/02
Sobi to Expand in South Korea via Rare Disease JV with Handok	13/02
US Futures, European Stocks Mixed	12/02
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	12/02
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox	12/02
Sobi's Growth Potential Remains 'Tremendous' Amid Conservative FY24 Outlook, RBC Says	09/02
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024	08/02
Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024	08/02
Swedish Orphan Biovitrum AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/02
Swedish Orphan Biovitrum AB Reports Earnings Results for the Full Year Ended December 31, 2023	08/02
Sobi's Profit to Get Royalty Boost as Sanofi Partnerships Outperform, RBC Says	02/02
Sobi to present new data at EAHAD 2024	31/01
Ericsson : nouveau directeur financier début avril	23/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Swedish Orphan Biovitrum AB

Azioni

SOBI

SE0000872095

Altre lingue

Filtri